A sharper look at the retina: new imaging technology may spot eye disease earlier

NCT ID NCT07725055

Not yet recruiting Knowledge-focused Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts Source: ClinicalTrials.gov ↗

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This study is testing whether a specialized eye scanner called the MONA IV can capture clear, detailed images of the retina's tiny cells and blood vessels. Researchers will use it in people with conditions like glaucoma or age-related macular degeneration, as well as in healthy volunteers. The goal is to see if this tool can reliably detect subtle changes that might signal early disease or progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MONA IV adaptive-optics scanning ophthalmoscope
What this could lead to: If successful, this imaging method could enable earlier detection of retinal damage, potentially improving monitoring of diseases like glaucoma and macular degeneration.
What could go wrong: This is an observational imaging study, not a treatment trial. The images may not prove useful for clinical decisions, and results may not generalize beyond the specific devices used.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration glaucoma retinal disorder retinitis pigmentosa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA ASSOCIATED WITH OTHER OCULAR DISORDERS RETINA DISORDER

More trials for these conditions

Other studies related to the condition(s) this trial covers.